跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 14,004 条关于
“C2N Diagnostic”
全部
14,004
临床试验
10,756
药物
252
机构
146
资讯
2,850
去年
Samsung Invests $10 Million in C2N Diagnostics to Advance Brain Health Diagnostics
去年
Splash Clinical and C2N Diagnostics Partner to Revolutionize Alzheimer's Trial Recruitment with Blood-Based Biomarkers
去年
PrecivityAD2 Blood Test Enhances Alzheimer's Diagnosis and Treatment Decisions
2个月前
SplashBIO Launches as Independent Platform Company to Tackle Alzheimer's Trial Screen Failures with Biomarker-Driven Pre-Screening
上个月
FDA Clears C2N Diagnostics' PrecivityAD2 Blood Test for Alzheimer's in Adults as Young as 40
6个月前
C2N Diagnostics Expands Alzheimer's Blood Test Access Across Asia Through Strategic Partnerships
去年
Blood Tests Offer Hope for Earlier, Easier Alzheimer's Diagnosis
2年前
FNIH Study Validates Blood Tests for Alzheimer's Detection, Potentially Replacing Invasive Spinal Taps
去年
Benfotiamine Enters Phase 2 Trial as Novel Alzheimer's Treatment
2年前
FDA to Convene Advisory Committee for Eli Lilly's Alzheimer's Drug Donanemab
第 1 页,共 285 页
上一页
下一页